Abstract
While transjugular intrahepatic portosystemic shunt (TIPS) is a common therapy for cirrhotic patients with diuretic-resistant or diuretic-refractory ascites, some patients are unsuitable for the procedure for technical or medical reasons. We report our experience with the use of chronic intravenous albumin infusions to achieve diuresis in this difficult patient population and review the historic experience of chronic albumin infusions as a treatment for ascites. Nineteen patients with cirrhosis and diuretic-resistant or diuretic-refractory ascites who were deemed unsuitable for TIPS received outpatient intravenous albumin infusions (50 g) weekly for at least 4 weeks. The following endpoints were retrospectively recorded: serum sodium, serum creatinine, blood urea nitrogen, hematocrit, bilirubin, albumin, international normalized ratio, body weight, and Model for End-stage Liver Disease (MELD) score. The contraindicatoins for TIPS included the following: portal vein thrombosis, two; advanced age, one; encephalopathy, nine; hyperbilirubinemia, five; and other, two. Compared to pretreatment, posttreatment weight decreased in 17 patients, remained unchanged in 0 patients, and increased in 2 patients. The overall mean change in body weight (before vs. after therapy) was 8 lb (P < 0.05). The only significant change in biochemistries was an increase in serum albumin from 2.5 g/dl before therapy to 3.5 g/dl after therapy (P < 0.05). We conclude that (1) recurrent intravenous weekly albumin infusions resulted in significant loss of edema and ascites as measured by loss of body weight, and (2) clinicians may want to consider chronic albumin infusions for selected patients with refractory ascites who are not candidates for TIPS.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gines P, Cardenas A, Arroyo V, Rodes J: Management of cirrhosis and ascites. N Engl J Med 350:1646–1654, 2004
Moore KP, Wong F, Gines P, et al.: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 38:258–266, 2003
Janeway CA, Gibson ST, Woodruff LM, Heyl JT, Bailey GT, Newhouser LR:. Chemical, clinical and immunological studies on the products of human plasma fractionation: concentrated human serum albumin. J Clin Invest 23:465–491, 1944
Faloon WN, Echkardt RD, Murphy TL, Cooper AM, Davidson CS: An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 28:583–594, 1949
Havens WP, Bluemle LW: The effect of human serum albumin and mercurial diuretics on ascites in patients with hepatic cirrhosis. Gastroenterology 16:455–474, 1950
Patek AJ, Mankin H, Colcher H, Lowell A, Earle DP: The effects of intravenous infection of concentrated human serum albumin upon blood plasma, ascites and renal function in three patients with cirrhosis of the liver. J Clin Invest 27:135–145, 1948
Kunkel HG, Labby DH, Ahrens EH, Shank RE, Hoagland CL: The use of concentrated human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest 27:305–320, 1948
Watson CJ, Greenberg A: Certain effects of salt poor human albumin in cases of hepatic disease. Am J Med Sci 217:651–657, 1949
Dykes PW: A study of the effects of albumin infusions in patients with cirrhosis of the liver. Q J Med 30:297–327, 1961
Thorn GW, Armstrong SH, Davenport VD: Chemical, clinical, and immunological studies on the products of human plasma fractionation. XXXI. The use of salt–poor concentrated human serum albumin solution in the treatment of hepatic cirrhosis. J Clin Invest 25:304–323, 1946
Post J, Rose JV, Shore SM: Intravenous use of salt-poor human albumin. Arch Intern Med 87:775–788, 1954
Schindler C, Ramadori G: Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites. J Hepatol 31:1132, 1999
Gentilini P, Casini-Raggi V, DiFiore GD, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 30:639–645, 1999
Blendis L, Wong F: Intravenous albumin with diuretics: protean lesions to be learnt? J Hepatol 30:727–730, 1999
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trotter, J., Pieramici, E. & Everson, G.T. Chronic Albumin Infusions to Achieve Diuresis in Patients with Ascites Who Are Not Candidates for Transjugular Intrahepatic Portosystemic Shunt (TIPS). Dig Dis Sci 50, 1356–1360 (2005). https://doi.org/10.1007/s10620-005-2787-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2787-2